샘플 요청 목록

 카트 문의
시장보고서
상품코드
1731964

세계의 조울증 치료 시장

Bipolar Disorder Treatment
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 387 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 조울증 치료 시장은 2030년까지 67억 달러에 달할 전망

2024년에 52억 달러로 추정되는 세계의 조울증 치료 시장은 분석 기간인 2024-2030년에 CAGR 4.2%로 성장하며, 2030년에는 67억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 약물 요법은 CAGR 5.5%를 기록하며, 분석 기간 종료시에는 25억 달러에 달할 것으로 예측됩니다. 정신요법 분야의 성장률은 분석 기간 중 CAGR 2.6%로 추정됩니다.

미국 시장은 14억 달러로 추정, 중국은 CAGR 7.8%로 성장 예측

미국의 조울증 치료 시장은 2024년에 14억 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2024-2030년의 분석 기간에 CAGR 7.8%로 추이하며, 2030년에는 14억 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 1.6%와 3.3%로 예측됩니다. 유럽에서는 독일이 CAGR 2.4%로 성장할 것으로 예측됩니다.

세계의 조울증 치료 시장 - 주요 동향과 촉진요인 정리

양극성 장애 치료가 전 세계 정신 헬스케어의 틀에서 다시 주목받는 이유는 무엇인가?

조증과 우울증이 번갈아 나타나는 양극성 장애는 진단율 증가, 정신질환에 대한 인식 증가, 공중보건 시스템에 대한 큰 부담으로 인해 임상적으로나 상업적으로 많은 관심을 받고 있습니다. 전 세계에서 수백만 명이 앓고 있는 이 질환은 종종 기능 장애와 동반 질환을 유발하고, 치료하지 않고 방치할 경우 자살 위험을 증가시키기 때문에 적시에 효과적인 개입이 필수적입니다. 정신건강 서비스에 대한 접근성이 확대되고, 1차 의료에 행동 건강이 통합되고, 낙인찍기가 줄어들면서 전 세계에서 양극성 장애에 대한 종합적인 치료에 대한 수요가 증가하고 있습니다.

치료 프로토콜은 일반적으로 장기적이고 다각적이며, 기분안정제, 비정형 항정신병제물, 항우울제를 통한 약리학적 관리와 심리사회적 치료를 포함합니다. 양극성 장애의 만성적 특성과 지속적인 유지, 재발 방지, 부작용 관리의 필요성은 안전하고 효과적이며 환자 개개인에 맞는 치료 옵션의 전략적 중요성을 강조합니다. 정신건강이 세계 헬스케어 의제에서 높은 순위를 차지하고 있는 가운데, 양극성 장애는 투자, 연구 및 혁신의 중심 치료 영역으로 남아 있습니다.

약물 치료와 디지털 정신 의학의 발전은 어떻게 치료 모델을 변화시키고 있는가?

약리학적 혁신은 양극성 장애 치료의 발전을 계속 주도하고 있으며, 새로운 세대의 비정형 항정신병 약물은 안전성 프로파일을 개선하고 조증과 우울증 에피소드 모두에 걸쳐 기분을 안정화시킵니다. 장기 지속형 주사제는 치료가 어려운 환자군의 유지 요법과 복약 순응도를 위해 지지받고 있습니다. 이와 함께 수면 조절, 불안 증상, 인지 기능 장애를 표적으로 하는 보조 요법이 보다 섬세한 증상 조절을 위한 약리학적 툴키트을 확장하고 있습니다.

디지털 정신의학은 원격 모니터링, 앱 기반 기분 추적, 원격 정신의학 플랫폼, AI 기반 예측 툴 등을 통해 치료 제공의 형태를 바꾸고 있습니다. 이러한 기술은 재발을 조기에 발견하고, 개인화된 약물 조정을 지원하며, 자가 관리 전략에 대한 참여를 증가시킬 수 있습니다. 임상 연구에서 디지털 페노타이핑과 리얼월드 증거 툴은 임상시험 등록을 가속화하고, 데이터 세분화를 개선하며, 환자 중심의 의약품 개발을 지원하고 있습니다. 이러한 발전은 양극성 장애에 대한 보다 지속적 이고 적극적이며 통합적인 치료 경로를 가능하게 하고 있습니다.

양극성 장애 치료에 대한 수요가 증가하고 있는 시장과 성장을 주도하고 있는 환자 부문은?

북미와 유럽이 양극성 장애 치료의 주요 시장으로, 탄탄한 정신건강 인프라, 보험 적용, 높은 인지도를 바탕으로 하고 있습니다. 미국은 항정신병제물 및 기분안정제 처방량이 많고, 디지털 정신건강 플랫폼의 도입이 활발히 이루어지고 있으며, 여전히 큰 기여를 하고 있습니다. 아시아태평양에서는 일본, 호주, 한국, 인도 등의 국가에서 진단율 증가, 공공 정신건강 구상, 정신과 치료제에 대한 접근성 향상 등이 시장 확대의 원동력이 되고 있습니다.

주요 환자군으로는 조발성 양극성 장애가 많은 청소년 및 청년층, 치료 저항성 및 빠른 주기를 보이는 성인 등이 있습니다. 또한 양극성 장애의 증상이 인지기능 저하 및 후기 우울증과 겹칠 수 있으며, 전문적인 관리가 필요한 노인층 수요도 증가하고 있습니다. 불안장애, ADHD, 약물사용장애와 같은 정신질환의 동반은 치료의 복잡성을 더욱 증가시켜 통합적, 다학제적 치료의 필요성을 더욱 높이고 있습니다.

양극성 장애 치료 시장의 세계 성장 원동력은?

양극성 장애 치료 시장의 세계 성장의 원동력은 정신건강에 대한 인식 증가, 스크리닝 프로토콜의 개선, 약리 및 비약물 치료 모두에 대한 접근성 확대입니다. 정신보건 예산을 확대하고, 편견을 없애고, 행동치료를 1차의료 시스템에 통합하려는 정부의 구상은 보다 광범위한 치료를 촉진하고 있습니다. 사회경제적 스트레스 요인과 팬데믹 이후 정신건강 동향에 의해 증폭된 기분 장애의 유병률 증가는 양극성 장애를 최우선 치료 대상으로 강화시키고 있습니다.

제약 혁신, 디지털 헬스 통합, 부문 간 파트너십은 치료의 연속성을 재구축하고 보다 목표 지향적이고 지속가능한 치료 모델을 가능하게 하고 있습니다. 지불자와 의료 서비스 프로바이더가 장기적으로 비용 효율적인 솔루션을 모색하는 가운데, 순응도 지원, 기능적 결과, 재발 예방에 대한 중요성이 강조되고 있습니다. 이러한 배경 속에서 이 분야의 궤도를 결정짓는 중요한 질문이 있습니다. 양극성 장애 치료 생태계가 전체론적이고, 접근성이 용이하며, 환자 맞춤형 치료를 제공할 수 있을 만큼 빠르게 진화할 수 있는가?

부문

치료 유형(약물 요법, 정신요법, 전기경련 요법, 경두개 자기 자극치료, 기타 치료 유형), 조울증 유형(조울증 i형, 조울증 II형, 사이크로사이믹크 장애, 기타 조울증 유형), 최종사용자(병원, 전문 클리닉, 정신건강 센터, 외래 수술 센터)

조사 대상 기업의 예(주목 합계 42사)

  • AbbVie Inc.
  • Alkermes plc
  • Allergan plc
  • Amgen Inc.
  • AstraZeneca plc
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • Gedeon Richter Plc
  • GlaxoSmithKline plc(GSK)
  • H. Lundbeck A/S
  • Indivior PLC
  • Intra-Cellular Therapies Inc.
  • Janssen Pharmaceuticals Inc.
  • Johnson & Johnson
  • Minerva Neurosciences Inc.
  • Novartis AG
  • Otsuka Holdings Co., Ltd.
  • Pfizer Inc.
  • Sumitomo Pharma Co., Ltd.
  • Teva Pharmaceutical Industries Ltd.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 인위적인 수입원가 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

Global Industry Analysts는 세계 주요 수석 이코노미스트(1,4,949명), 싱크탱크(62개 기관), 무역 및 산업 단체(171개 기관)의 전문가들의 의견을 면밀히 검토하여 생태계에 미치는 영향을 평가하고 새로운 시장 현실에 대응하고 있습니다. 모든 주요 국가의 전문가와 경제학자들이 관세와 그것이 자국에 미치는 영향에 대한 의견을 추적 조사했습니다.

Global Industry Analysts는 이러한 혼란이 향후 2-3개월 내에 마무리되고 새로운 세계 질서가 보다 명확하게 확립될 것으로 예상하고 있으며, Global Industry Analysts는 이러한 상황을 실시간으로 추적하고 있습니다.

2025년 4월: 협상 단계

이번 4월 보고서에서는 관세가 세계 시장 전체에 미치는 영향과 지역별 시장 조정에 대해 소개합니다. 당사의 예측은 과거 데이터와 진화하는 시장 영향요인을 기반으로 합니다.

2025년 7월: 최종 관세 재설정

고객님들께는 각 국가별 최종 리셋이 발표된 후 7월에 무료 업데이트 버전을 제공해 드립니다. 최종 업데이트 버전에는 명확하게 정의된 관세 영향 분석이 포함되어 있습니다.

상호 및 양자 간 무역과 관세의 영향 분석 :

미국 <>중국 <>멕시코 <>캐나다 <>EU <>일본 <>인도 <>기타 176개국

업계 최고의 이코노미스트: Global Industry Analysts의 지식 기반은 국가, 싱크탱크, 무역 및 산업 단체, 대기업, 그리고 세계 계량 경제 상황의 전례 없는 패러다임 전환의 영향을 공유하는 분야별 전문가 등 가장 영향력 있는 수석 이코노미스트 그룹을 포함한 14,949명의 이코노미스트를 추적하고 있습니다. 16,491개 이상의 보고서 대부분에 마일스톤에 기반한 2단계 출시 일정이 적용되어 있습니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 25.06.16

Global Bipolar Disorder Treatment Market to Reach US$6.7 Billion by 2030

The global market for Bipolar Disorder Treatment estimated at US$5.2 Billion in the year 2024, is expected to reach US$6.7 Billion by 2030, growing at a CAGR of 4.2% over the analysis period 2024-2030. Pharmacotherapy, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$2.5 Billion by the end of the analysis period. Growth in the Psychotherapy segment is estimated at 2.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.4 Billion While China is Forecast to Grow at 7.8% CAGR

The Bipolar Disorder Treatment market in the U.S. is estimated at US$1.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2030 trailing a CAGR of 7.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 3.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.4% CAGR.

Global Bipolar Disorder Treatment Market - Key Trends & Drivers Summarized

Why Is Bipolar Disorder Treatment Gaining Renewed Focus Within Global Mental Health Care Frameworks?

Bipolar disorder, characterized by alternating episodes of mania and depression, is gaining increased clinical and commercial attention due to rising diagnosis rates, growing awareness of psychiatric disorders, and its significant burden on public health systems. Affecting millions worldwide, the condition often leads to impaired functioning, comorbidities, and elevated suicide risk if left untreated-making timely and effective intervention critical. With expanding access to mental health services, integration of behavioral health into primary care, and destigmatization efforts, the demand for comprehensive bipolar disorder treatment is intensifying globally.

Treatment protocols are typically long-term and multifaceted, encompassing pharmacological management with mood stabilizers, atypical antipsychotics, and antidepressants, along with psychosocial therapies. The chronic nature of bipolar disorder and the need for ongoing maintenance, relapse prevention, and side effect management underscore the strategic importance of safe, efficacious, and individualized treatment options. As mental health rises on the global healthcare agenda, bipolar disorder remains a core therapeutic area for investment, research, and innovation.

How Are Advancements in Pharmacotherapy and Digital Psychiatry Transforming Treatment Models?

Pharmacological innovation continues to drive progress in bipolar disorder treatment, with new-generation atypical antipsychotics offering improved safety profiles and mood stabilization across both manic and depressive episodes. Long-acting injectable formulations are gaining traction for maintenance therapy and medication adherence in difficult-to-treat populations. In parallel, adjunctive therapies targeting sleep regulation, anxiety symptoms, and cognitive dysfunction are expanding the pharmacological toolkit for more nuanced symptom control.

Digital psychiatry is also reshaping care delivery through remote monitoring, app-based mood tracking, telepsychiatry platforms, and AI-enabled predictive tools. These technologies enhance early relapse detection, support personalized medication adjustments, and increase engagement in self-management strategies. In clinical research, digital phenotyping and real-world evidence tools are accelerating trial enrollment and improving data granularity-supporting more patient-centric drug development. Together, these advancements are enabling more continuous, proactive, and integrated treatment pathways for bipolar disorder.

Where Is Demand for Bipolar Disorder Treatment Increasing and Which Patient Segments Are Driving Growth?

North America and Europe are the leading markets for bipolar disorder treatment, supported by robust mental health infrastructure, insurance coverage, and high awareness levels. The U.S. remains a major contributor, with strong prescription volumes for antipsychotics and mood stabilizers, as well as growing adoption of digital mental health platforms. In Asia-Pacific, market expansion is being driven by increasing diagnosis rates, public mental health initiatives, and improved access to psychiatric medications in countries such as Japan, Australia, South Korea, and India.

Key patient segments include adolescents and young adults-where early-onset bipolar disorder often presents-and adults with treatment-resistant or rapid-cycling forms of the illness. Demand is also rising among elderly populations, where bipolar symptoms may overlap with cognitive decline or late-life depression, requiring specialized management. Psychiatric comorbidities such as anxiety, ADHD, and substance use disorders are further shaping treatment complexity and driving the need for integrated, multidisciplinary care.

What Is Fueling the Global Growth of the Bipolar Disorder Treatment Market?

The global growth of the bipolar disorder treatment market is fueled by rising mental health awareness, improved screening protocols, and expanding access to both pharmacological and non-pharmacological therapies. Government efforts to scale mental health budgets, reduce stigma, and integrate behavioral care into primary systems are fostering broader treatment reach. The increasing prevalence of mood disorders, amplified by socio-economic stressors and post-pandemic mental health trends, is reinforcing bipolar disorder as a high-priority therapeutic focus.

Pharmaceutical innovation, digital health integration, and cross-sector partnerships are reshaping the care continuum and enabling more targeted, sustainable treatment models. As payers and providers seek long-term cost-effective solutions, there is growing emphasis on adherence support, functional outcomes, and relapse prevention. Against this backdrop, a critical question defines the sector’s trajectory: Can the bipolar disorder treatment ecosystem evolve quickly enough to deliver holistic, accessible, and patient-tailored care-while addressing the lifelong nature and clinical complexity of this challenging mental health condition?

SCOPE OF STUDY:

The report analyzes the Bipolar Disorder Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Treatment Type (Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation, Other Treatment Types); Bipolar Disorder Type (Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder, Other Bipolar Disorder Types); End-Use (Hospitals, Specialty Clinics, Mental Health Centers, Ambulatory Surgery Centers)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • AbbVie Inc.
  • Alkermes plc
  • Allergan plc
  • Amgen Inc.
  • AstraZeneca plc
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • Gedeon Richter Plc
  • GlaxoSmithKline plc (GSK)
  • H. Lundbeck A/S
  • Indivior PLC
  • Intra-Cellular Therapies Inc.
  • Janssen Pharmaceuticals Inc.
  • Johnson & Johnson
  • Minerva Neurosciences Inc.
  • Novartis AG
  • Otsuka Holdings Co., Ltd.
  • Pfizer Inc.
  • Sumitomo Pharma Co., Ltd.
  • Teva Pharmaceutical Industries Ltd.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Bipolar Disorder Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Mental Health Awareness Fuels Increased Diagnosis and Treatment of Bipolar Disorder
    • Next-Gen Mood Stabilizers and Atypical Antipsychotics Expand Therapeutic Options for Bipolar Management
    • Long-Acting Injectables and Sustained-Release Formulations Improve Medication Adherence
    • Multimodal Therapy Models Combining Pharmacological and Psychosocial Support Gain Clinical Favor
    • Growing Use of Digital Mental Health Tools Enhances Remote Monitoring and Patient Self-Management
    • Precision Psychiatry Approaches Incorporate Genomic and Biomarker-Guided Bipolar Treatment Strategies
    • Pediatric and Adolescent Bipolar Cases Prompt Demand for Age-Specific Dosing Protocols
    • Stigma Reduction Campaigns Encourage Treatment-Seeking Behavior Across Diverse Populations
    • Integration of Bipolar Screening in Primary Care and Telehealth Broadens Early Intervention Reach
    • Expanded Payer Coverage for Mental Health Services Increases Access to New-Generation Bipolar Drugs
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Bipolar Disorder Treatment Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Bipolar Disorder Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Bipolar Disorder Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Pharmacotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Pharmacotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Pharmacotherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Psychotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Psychotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Psychotherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Electroconvulsive Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Electroconvulsive Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Transcranial Magnetic Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Transcranial Magnetic Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Transcranial Magnetic Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Treatment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Treatment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other Treatment Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Specialty Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Mental Health Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Mental Health Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Mental Health Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Bipolar I Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Bipolar I Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Bipolar I Disorder by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Bipolar II Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Bipolar II Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Bipolar II Disorder by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Cyclothymic Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Cyclothymic Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Cyclothymic Disorder by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Other Bipolar Disorder Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Other Bipolar Disorder Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for Other Bipolar Disorder Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Bipolar Disorder Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 44: USA Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Canada 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
  • JAPAN
    • Bipolar Disorder Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
  • CHINA
    • Bipolar Disorder Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 71: China Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: China 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: China 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
  • EUROPE
    • Bipolar Disorder Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Bipolar Disorder Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Bipolar Disorder Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Europe 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
  • FRANCE
    • Bipolar Disorder Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 92: France Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: France 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 98: France Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: France 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
  • GERMANY
    • Bipolar Disorder Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Germany 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Germany 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Italy 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 116: Italy Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Italy Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Italy 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Bipolar Disorder Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 119: UK Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: UK 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 125: UK Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: UK Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: UK 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Spain 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 131: Spain Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Spain Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Spain 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 134: Spain Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Spain Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Spain 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Russia 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 140: Russia Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Russia Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Russia 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 143: Russia Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Russia Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Russia 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of Europe Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Rest of Europe 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of Europe Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Rest of Europe 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Bipolar Disorder Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Bipolar Disorder Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Bipolar Disorder Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Asia-Pacific 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Asia-Pacific Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Asia-Pacific 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Bipolar Disorder Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Australia 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 170: Australia Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Australia Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Australia 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 173: Australia Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Australia Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Australia 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
  • INDIA
    • Bipolar Disorder Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 176: India Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: India 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 179: India Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: India Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: India 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 182: India Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: India Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: India 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: South Korea 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 188: South Korea Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: South Korea Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: South Korea 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 191: South Korea Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: South Korea Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: South Korea 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Asia-Pacific Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Asia-Pacific Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Asia-Pacific 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Bipolar Disorder Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Bipolar Disorder Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Bipolar Disorder Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Latin America 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 209: Latin America Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Latin America Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Latin America 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 212: Latin America Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Latin America Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Latin America 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Argentina 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 218: Argentina Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Argentina Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Argentina 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 221: Argentina Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Argentina Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Argentina 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Brazil 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 227: Brazil Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Brazil Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Brazil 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 230: Brazil Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Brazil Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Brazil 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Mexico 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 236: Mexico Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Mexico Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Mexico 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 239: Mexico Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Mexico Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Mexico 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Latin America 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Rest of Latin America Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Rest of Latin America 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Rest of Latin America Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Rest of Latin America 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Bipolar Disorder Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Bipolar Disorder Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Bipolar Disorder Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Middle East 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 257: Middle East Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Middle East Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Middle East 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 260: Middle East Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Middle East Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Middle East 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Iran 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 266: Iran Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Iran Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Iran 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 269: Iran Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Iran Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Iran 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Israel 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 275: Israel Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Israel Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: Israel 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 278: Israel Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Israel Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: Israel 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: Saudi Arabia 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Saudi Arabia Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: Saudi Arabia 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Saudi Arabia Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: Saudi Arabia 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: UAE 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 293: UAE Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: UAE Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: UAE 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 296: UAE Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: UAE Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: UAE 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Middle East 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Middle East Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Rest of Middle East 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Rest of Middle East Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 307: Rest of Middle East 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030
  • AFRICA
    • Bipolar Disorder Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Bipolar Disorder Treatment by Treatment Type - Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 310: Africa 15-Year Perspective for Bipolar Disorder Treatment by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy, Transcranial Magnetic Stimulation and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 311: Africa Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Africa Historic Review for Bipolar Disorder Treatment by End-Use - Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 313: Africa 15-Year Perspective for Bipolar Disorder Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Mental Health Centers and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 314: Africa Recent Past, Current & Future Analysis for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Africa Historic Review for Bipolar Disorder Treatment by Bipolar Disorder Type - Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 316: Africa 15-Year Perspective for Bipolar Disorder Treatment by Bipolar Disorder Type - Percentage Breakdown of Value Sales for Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder and Other Bipolar Disorder Types for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제